These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 26786779)

  • 1. Methionine sulfoxide reductase A affects β-amyloid solubility and mitochondrial function in a mouse model of Alzheimer's disease.
    Moskovitz J; Du F; Bowman CF; Yan SS
    Am J Physiol Endocrinol Metab; 2016 Mar; 310(6):E388-93. PubMed ID: 26786779
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction of methionine-sulfoxide reductases protects neurons from amyloid β-protein insults in vitro and in vivo.
    Moskovitz J; Maiti P; Lopes DH; Oien DB; Attar A; Liu T; Mittal S; Hayes J; Bitan G
    Biochemistry; 2011 Dec; 50(49):10687-97. PubMed ID: 22059533
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mitochondria are a direct site of A beta accumulation in Alzheimer's disease neurons: implications for free radical generation and oxidative damage in disease progression.
    Manczak M; Anekonda TS; Henson E; Park BS; Quinn J; Reddy PH
    Hum Mol Genet; 2006 May; 15(9):1437-49. PubMed ID: 16551656
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pyroglutamate-modified amyloid-β protein demonstrates similar properties in an Alzheimer's disease familial mutant knock-in mouse and Alzheimer's disease brain.
    Wu G; Miller RA; Connolly B; Marcus J; Renger J; Savage MJ
    Neurodegener Dis; 2014; 14(2):53-66. PubMed ID: 24158021
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amyloid precursor protein drives down-regulation of mitochondrial oxidative phosphorylation independent of amyloid beta.
    Lopez Sanchez MIG; Waugh HS; Tsatsanis A; Wong BX; Crowston JG; Duce JA; Trounce IA
    Sci Rep; 2017 Aug; 7(1):9835. PubMed ID: 28852095
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oxidation of methionine 35 reduces toxicity of the amyloid beta-peptide(1-42) in neuroblastoma cells (IMR-32) via enzyme methionine sulfoxide reductase A expression and function.
    Misiti F; Clementi ME; Giardina B
    Neurochem Int; 2010 Mar; 56(4):597-602. PubMed ID: 20060866
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytoplasmic gelsolin increases mitochondrial activity and reduces Abeta burden in a mouse model of Alzheimer's disease.
    Antequera D; Vargas T; Ugalde C; Spuch C; Molina JA; Ferrer I; Bermejo-Pareja F; Carro E
    Neurobiol Dis; 2009 Oct; 36(1):42-50. PubMed ID: 19607917
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elevated levels of brain-pathologies associated with neurodegenerative diseases in the methionine sulfoxide reductase A knockout mouse.
    Pal R; Oien DB; Ersen FY; Moskovitz J
    Exp Brain Res; 2007 Jul; 180(4):765-74. PubMed ID: 17333008
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mitochondrial dysfunction in a transgenic mouse model expressing human amyloid precursor protein (APP) with the Arctic mutation.
    Rönnbäck A; Pavlov PF; Mansory M; Gonze P; Marlière N; Winblad B; Graff C; Behbahani H
    J Neurochem; 2016 Feb; 136(3):497-502. PubMed ID: 26500157
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mitochondrial methionine sulfoxide reductase B2 links oxidative stress to Alzheimer's disease-like pathology.
    Xiang XJ; Song L; Deng XJ; Tang Y; Min Z; Luo B; Wen QX; Li KY; Chen J; Ma YL; Zhu BL; Yan Z; Chen GJ
    Exp Neurol; 2019 Aug; 318():145-156. PubMed ID: 31078523
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mitochondrial amyloid-beta levels are associated with the extent of mitochondrial dysfunction in different brain regions and the degree of cognitive impairment in Alzheimer's transgenic mice.
    Dragicevic N; Mamcarz M; Zhu Y; Buzzeo R; Tan J; Arendash GW; Bradshaw PC
    J Alzheimers Dis; 2010; 20 Suppl 2():S535-50. PubMed ID: 20463404
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mitochondria and vascular lesions as a central target for the development of Alzheimer's disease and Alzheimer disease-like pathology in transgenic mice.
    Aliev G; Seyidova D; Lamb BT; Obrenovich ME; Siedlak SL; Vinters HV; Friedland RP; LaManna JC; Smith MA; Perry G
    Neurol Res; 2003 Sep; 25(6):665-74. PubMed ID: 14503022
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship between ubiquilin-1 and BACE1 in human Alzheimer's disease and APdE9 transgenic mouse brain and cell-based models.
    Natunen T; Takalo M; Kemppainen S; Leskelä S; Marttinen M; Kurkinen KMA; Pursiheimo JP; Sarajärvi T; Viswanathan J; Gabbouj S; Solje E; Tahvanainen E; Pirttimäki T; Kurki M; Paananen J; Rauramaa T; Miettinen P; Mäkinen P; Leinonen V; Soininen H; Airenne K; Tanzi RE; Tanila H; Haapasalo A; Hiltunen M
    Neurobiol Dis; 2016 Jan; 85():187-205. PubMed ID: 26563932
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methionine Sulfoxide Reductase A Deficiency Exacerbates Cisplatin-Induced Nephrotoxicity via Increased Mitochondrial Damage and Renal Cell Death.
    Noh MR; Kim KY; Han SJ; Kim JI; Kim HY; Park KM
    Antioxid Redox Signal; 2017 Oct; 27(11):727-741. PubMed ID: 28158949
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of amyloid-beta (Abeta) peptide-binding alcohol dehydrogenase-Abeta interaction reduces Abeta accumulation and improves mitochondrial function in a mouse model of Alzheimer's disease.
    Yao J; Du H; Yan S; Fang F; Wang C; Lue LF; Guo L; Chen D; Stern DM; Gunn Moore FJ; Xi Chen J; Arancio O; Yan SS
    J Neurosci; 2011 Feb; 31(6):2313-20. PubMed ID: 21307267
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mitochondrial targeting and a novel transmembrane arrest of Alzheimer's amyloid precursor protein impairs mitochondrial function in neuronal cells.
    Anandatheerthavarada HK; Biswas G; Robin MA; Avadhani NG
    J Cell Biol; 2003 Apr; 161(1):41-54. PubMed ID: 12695498
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rho-associated protein kinase 1 (ROCK1) is increased in Alzheimer's disease and ROCK1 depletion reduces amyloid-β levels in brain.
    Henderson BW; Gentry EG; Rush T; Troncoso JC; Thambisetty M; Montine TJ; Herskowitz JH
    J Neurochem; 2016 Aug; 138(4):525-31. PubMed ID: 27246255
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of focal brain injury on beta-amyloid plaque deposition, inflammation and synapses in the APP/PS1 mouse model of Alzheimer's disease.
    Collins JM; King AE; Woodhouse A; Kirkcaldie MT; Vickers JC
    Exp Neurol; 2015 May; 267():219-29. PubMed ID: 25747037
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Donepezil attenuates Aβ-associated mitochondrial dysfunction and reduces mitochondrial Aβ accumulation in vivo and in vitro.
    Ye CY; Lei Y; Tang XC; Zhang HY
    Neuropharmacology; 2015 Aug; 95():29-36. PubMed ID: 25744714
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MH84 improves mitochondrial dysfunction in a mouse model of early Alzheimer's disease.
    Pohland M; Pellowska M; Asseburg H; Hagl S; Reutzel M; Joppe A; Berressem D; Eckert SH; Wurglics M; Schubert-Zsilavecz M; Eckert GP
    Alzheimers Res Ther; 2018 Feb; 10(1):18. PubMed ID: 29433569
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.